CDIO — Cardio Diagnostics Holdings Income Statement
0.000.00%
Last trade - 00:00- $25.24m
- $17.72m
- $0.03m
Annual income statement for Cardio Diagnostics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.001 | 0.001 | 0.017 | 0.035 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.609 | 0.621 | 4.66 | 7.07 | 8.4 |
| Operating Profit | -0.609 | -0.62 | -4.66 | -7.05 | -8.37 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.605 | -0.62 | -4.66 | -8.38 | -8.38 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.605 | -0.62 | -4.66 | -8.38 | -8.38 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.605 | -0.62 | -4.66 | -8.38 | -8.38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.605 | -0.62 | -4.66 | -8.38 | -8.38 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.064 | -0.065 | -0.478 | -0.676 | -0.312 |
| Dividends per Share |